Code | 4971B | ||||||||||
MA number | 21/0268/15-S | ||||||||||
Product Form: | cps dur 100x300 mg (fľ.HDPE s LDPE viečkom) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 20.07.2015 |
PIL: | PIL_Brieka_06.2024.pdf |
SPC: | SPC_Brieka_06.2024.pdf |
Safety feature | Yes |
Data update: | 14.11.2023 |